Christine Miaskowski, PhD, RN, University of California, San Francisco
This study was designed to identify both signs and symptoms of breast cancer-related lymphedema and genetic factors that predict whether patients are at increased risk for developing lymphedema. The researchers intend to use the results to develop and test new approaches to prevent or reduce the risk of lymphedema developing following breast cancer treatment.
The initial Call to Action for this study was on 04/25/2017 and the researchers closed enrollment on 04/06/2020. The Love Research Army provided them with 194 participants who were interested in enrolling in the study.